64 related articles for article (PubMed ID: 24841766)
1. Mammalian sterile-like 1 kinase inhibits TGFβ and EGF‑dependent regulation of invasiveness, migration and proliferation of HEC-1-A endometrial cancer cells.
Attarha S; Andersson S; Mints M; Souchelnytskyi S
Int J Oncol; 2014 Aug; 45(2):853-60. PubMed ID: 24841766
[TBL] [Abstract][Full Text] [Related]
2. PKN1 modulates TGFβ and EGF signaling in HEC-1-A endometrial cancer cell line.
Attarha S; Saini RK; Andersson S; Mints M; Souchelnytskyi S
Onco Targets Ther; 2014; 7():1397-408. PubMed ID: 25120372
[TBL] [Abstract][Full Text] [Related]
3. Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGFβ pathway.
Bokhari AA; Lee LR; Raboteau D; Hamilton CA; Maxwell GL; Rodriguez GC; Syed V
Cancer Prev Res (Phila); 2014 Oct; 7(10):1045-55. PubMed ID: 25070663
[TBL] [Abstract][Full Text] [Related]
4. Comments on the cross-talk of TGFβ and EGF in cancer.
Jia M; Souchelnytstkyi S
Exp Oncol; 2011 Sep; 33(3):170-3. PubMed ID: 21956473
[No Abstract] [Full Text] [Related]
5. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the antiproliferative effect of TGFbeta by EGF in primary human ovarian cancer cells.
Dunfield LD; Nachtigal MW
Oncogene; 2003 Jul; 22(30):4745-51. PubMed ID: 12879019
[TBL] [Abstract][Full Text] [Related]
7. Interactome of transforming growth factor-beta type I receptor (TbetaRI): inhibition of TGFbeta signaling by Epac1.
Conrotto P; Yakymovych I; Yakymovych M; Souchelnytskyi S
J Proteome Res; 2007 Jan; 6(1):287-97. PubMed ID: 17203972
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
Reynolds RK; Hu C; Baker VV
Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
[TBL] [Abstract][Full Text] [Related]
9. [In vitro study on the effect of sex steroid and growth factor on growth and laminin, collagen IV, and tissue plasminogen activator production of normal endometrial cells and endometrial cancer cells in culture].
Ueda M; Ueki M; Tsurunaga T; Yamada T; Okamoto Y; Seiki Y; Iwai E; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1219-26. PubMed ID: 1431434
[TBL] [Abstract][Full Text] [Related]
10. Impact of combinations of EGF, TGFβ, 17β-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines.
Mints M; Souchelnytskyi S
Exp Oncol; 2014 Jun; 36(2):67-71. PubMed ID: 24980758
[TBL] [Abstract][Full Text] [Related]
11. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
12. Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro.
Mochizuki T; Sakai K; Iwashita M
Growth Horm IGF Res; 2006 Jun; 16(3):202-10. PubMed ID: 16844395
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor stimulates proliferation and migration of porcine trophectoderm cells through protooncogenic protein kinase 1 and extracellular-signal-regulated kinases 1/2 mitogen-activated protein kinase signal transduction cascades during early pregnancy.
Jeong W; Kim J; Bazer FW; Song G
Mol Cell Endocrinol; 2013 Dec; 381(1-2):302-11. PubMed ID: 24012778
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C alpha (PKCalpha) regulates growth and invasion of endometrial cancer cells.
Haughian JM; Bradford AP
J Cell Physiol; 2009 Jul; 220(1):112-8. PubMed ID: 19235902
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
16. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Mst1 in tumor necrosis factor-alpha-induced apoptosis of endothelial cells.
Ohtsubo H; Ichiki T; Imayama I; Ono H; Fukuyama K; Hashiguchi Y; Sadoshima J; Sunagawa K
Biochem Biophys Res Commun; 2008 Mar; 367(2):474-80. PubMed ID: 18182160
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
19. Opposing actions of TGFbeta and MAP kinase signaling in undifferentiated hen granulosa cells.
Woods DC; Haugen MJ; Johnson AL
Biochem Biophys Res Commun; 2005 Oct; 336(2):450-7. PubMed ID: 16139244
[TBL] [Abstract][Full Text] [Related]
20. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
He Y; Northey JJ; Primeau M; Machado RD; Trembath R; Siegel PM; Lamarche-Vane N
Oncogene; 2011 Mar; 30(9):1032-45. PubMed ID: 21042277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
